axicabtagene ciloleucel
daiichi sankyo,gilead
['yescarta', 'lymphoma', 'zuma-7', 'gilead']
#ash22: #gilead presented the two new analyses from the zuma-7 trial, demonstrating the efficacy of #yescarta as an earlier or second-line treatment in patients with relapsed or refractory large b-cell #lymphoma. #ash2022 #news #media #oncology #hematology
#iPharmaCenter is a #website which covers #pharmaceutical and #healthcare #news plus #blogs #diseases #drugs #healthcaresystems #globalhealth #pharma